CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-15 | Stern Sadie EVP Chief Human Resources Off | Grant or award | +1,671 | $0.00 | $2 | 13,461 |
| 2021-12-15 | Regan Barry J. EVP Operations | Grant or award | +1,671 | $0.00 | $2 | 13,128 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −200 | $528.06 | $106K | 84,505 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −148 | $529.78 | $78K | 84,357 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −25 | $530.44 | $13K | 84,332 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −300 | $531.87 | $160K | 84,032 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −100 | $532.92 | $53K | 83,932 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −500 | $534.84 | $267K | 83,432 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −250 | $536.01 | $134K | 83,182 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −271 | $537.08 | $146K | 82,911 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −527 | $538.15 | $284K | 82,384 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −179 | $539.32 | $97K | 82,205 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −200 | $540.40 | $108K | 82,005 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −200 | $541.39 | $108K | 81,805 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −50 | $542.06 | $27K | 81,755 |
| 2021-12-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −50 | $543.83 | $27K | 81,705 |
| 2021-12-14 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Gift | −5,459 | 35,120 | ||
| 2021-12-13 | Regan Barry J. EVP Operations | Sale | −1,214 | $563.93 | $685K | 11,457 |
| 2021-12-06 | Sylvain Jereme M EVP, Chief Financial Officer | Sale | −600 | $517.59 | $311K | 12,292 |
| 2021-12-01 | FOLETTA MARK G Director | Sale | −41 | $556.89 | $23K | 13,056 |
Page 28 of 40 · 785 trades